An excerpt from Dr. T’s Drop the Fat Diet: 12 Steps to Leaner You Forever. Semaglutide, a medication often marketed as Ozempic, Wegovy, or Rybelsus, has gained immense popularity in recent years. This is especially true in an age where diabetes a…
Category: Obesity
The Spandex dilemma: Does size still matter?
In today’s fashion landscape, one may wonder if size truly matters anymore. With the prevalence of spandex in clothing, determining one’s actual size has become a challenging feat. The question arises: what role does spandex play in the ong…
COVID vaccines and weight loss medications: a tale of 2 needles
I am perplexed by two different needles which, when viewed together, illustrate the irrational themes which dominate our shared humanity. They inform me that, despite being a doctor for more than twenty years, I honestly feel dumber each day about huma…
Unraveling the complex enigma of obesity [PODCAST]
Subscribe to The Podcast by KevinMD. Catch up on old episodes! We sit down with Franchell Hamilton, a bariatric surgeon, to explore the intriguing link between genetics, brain function, and obesity. She shares her insights into why many patients don…
5 things to know about weight from a bariatric surgeon
You’ve probably had friends and family corner you to look at a rash or talk about medications. With social media exploding about Ozempic, these questions and even curbsides from physicians have boomed. We all want to know more about weight. As a …
Contemporary weight loss: Unveiling the quest for elusive elixir
Recently, I received a call from an old friend. We had drifted apart over the years, but his purpose in calling wasn’t rooted in a desire to rekindle the embers of yesteryears. No. Rather, it was an explicit inquiry into whether I could assist hi…
Will Where You Live Determine Access and Coverage of Emerging Anti-Obesity Drugs?
The U.S. Midwest and South regions have higher average obesity rates among adults. What does this mean for access and coverage of prescription drugs for weight loss?
Drugs Used for Weight Loss Could Cost Americans Much More Than People in Peer Countries
In addition to having the highest obesity rates, the U.S is currently facing significantly higher prices for several major drugs used for weight loss and other health needs, according to a new KFF analysis of the list prices for semaglutide and tirzepa…
How Do Prices of Drugs for Weight Loss in the U.S. Compare to Peer Nations’ Prices?
A class of drugs initially approved for diabetes treatment has captured the public’s and policymakers’ attention as interest in their off-label use for weight loss rises. The weight-loss benefits of these drugs have led to their prescribed use for obes…
KFF Health News’ ‘What the Health?’: On Abortion Rights, Ohio Is the New Kansas
Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of KFF Health News join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the “Medicaid unwinding” is going, as millions have their eligibility for coverage rechecked.
